Evidence map›Paper›PMID 38680458›Full record

ArticleFrontiers in chemistry2024

Study of andrographolide bioactivity against

Lihui He, Lai Song, Xuanhao Li, Shibo Lin, Guodong Ye, Huanxiang Liu, Xiaotian Zhao

Abstract read
In one paragraph

Article in Frontiers in chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lihui He *Department of Pharmacy, Chengdu Second Peoples Hospital, Chengdu, China.
Lai Song *Department of Oncology, Chengdu Second Peoples Hospital, Chengdu, China.
Xuanhao LiDepartment of Pharmacy, Chengdu Second Peoples Hospital, Chengdu, China.
Shibo LinDepartment of Pharmacy, Chengdu Second Peoples Hospital, Chengdu, China.
Guodong YeThe Fifth Affiliated Hospital, Guangdong Provincial Key Laboratory of Molecular Target and Clinical Pharmacology, The NMPA and State Key Laboratory of Respiratory Disease, The School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou, China.
Huanxiang LiuCentre for Artificial Intelligence Driven Drug Discovery, Faculty of Applied Sciences, Macao Polytechnic University, Guangzhou, China.
Xiaotian ZhaoDepartment of Pharmacy, Chengdu Second Peoples Hospital, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Andrographolide is one of the main biologically active molecules isolated from

Indexed as

andrographolidebiofilmdensity functional theoryinhibitormolecular dockingmolecular dynamics

Identifiers

PMID38680458
PMCPMC11045890

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.